Juno Therapeutics increases its cancer treating T-cell research by acquiring Harvard spinout Abvitro, which focuses on diseases resistant to the immune system.

Pharmaceutical firm Strides Arcolab holds a 12% stake in the biosimilar developer after investing $9m in 2014.

Norwest-backed Threadflip has shut down and revealed a partnership with Le Tote, though neither company has disclosed whether the deal is a formal acquisition.

Appcelerator, which had raised approximately $91m in funding from investors including eBay, Sumitomo and RedHat, has been acquired in a cash deal of undisclosed size.

The Belgium-based stem cell therapy developer, which is backed by investors including Gri-Cel and Novartis, has filed to go public in the US.

The eye disease treatment developer has raised $48m in funding from investors including Santen Pharmaceutical, which is also a research partner.

Qualcomm has exited app monetisation company Heyzap in an acquisition by RTNS that could end up being worth up to $45m.

SoftBank is among the exiting investors as conglomerate Dalian Wanda acquires US film and comics producer Legendary Entertainment.

Alphabet has exited realty listings platform CommonFloor in a majority-stock purchase by Quikr that reportedly valued it at $100m to $120m.

Tencent-backed Meilishuo is set to be acquired by its competitor Mogujie in a stock deal, and the $3bn merged company could raise up to $250m in the aftermath.